当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:152.83亿  总市值:208.39亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金41,662,767,418.927,306,154,42111,974,375,550.6656,483,077,866.27
  收到的税费返还278,965.9172,277.364,378.49666,271.29
  收到其他与经营活动有关的现金439,687,973.94218,676,012.37153,374,814.3841,752,743.23
  经营活动现金流入小计42,102,734,358.7427,525,002,710.7312,127,754,743.4557,325,496,880.79
  购买商品、接受劳务支付的现金41,456,414,728.4728,025,948,968.614,500,335,656.4951,550,999,642.4
  支付给职工以及为职工支付的现金619,266,999.47433,124,345.43236,106,843.75854,542,592.38
  支付的各项税费1,105,924,192.39836,414,856.6419,149,061.641,771,229,006.98
  支付其他与经营活动有关的现金1,327,947,382.63863,858,088.85565,113,976.971,143,208,126.97
  经营活动现金流出小计44,509,553,302.9630,159,346,259.4815,720,705,538.8555,319,979,368.73
  经营活动产生的现金流量净额-2,406,818,944.22-2,634,343,548.75-3,592,950,795.42,005,517,512.06
二、投资活动产生的现金流量:
  收回投资收到的现金3,094,248.873,094,248.873,094,248.8718,329,499.93
  取得投资收益收到的现金46,933,240.6145,986,567.23-32,273,886.78
  处置固定资产、无形资产和其他长期资产收回的现金净额28,400.218,292.25,107.2202,302.25
  处置子公司及其他营业单位收到的现金净额38,437,200---
  收到的其他与投资活动有关的现金-500,000,000--
  投资活动现金流入小计88,493,089.68549,099,108.33,099,356.0750,805,688.96
  购建固定资产、无形资产和其他长期资产支付的现金41,485,185.3329,269,085.956,420,132.868,194,378.17
  支付其他与投资活动有关的现金365,000,000---
  投资活动现金流出小计406,485,185.3329,269,085.956,420,132.868,194,378.17
  投资活动产生的现金流量净额-317,992,095.65519,830,022.35-3,320,776.73-17,388,689.21
三、筹资活动产生的现金流量:
  取得借款收到的现金216,000,000216,000,000106,000,000319,447,721.2
  筹资活动现金流入小计216,000,000216,000,000106,000,000319,447,721.2
  偿还债务支付的现金271,918,654.86174,449,759.21148,363,906.68923,448,321.92
  分配股利、利润或偿付利息支付的现金787,012,503.81610,652,630.074,892,203.06653,281,757.75
  其中:子公司支付给少数股东的股利、利润171,981,588.17--27,543,689.51
  支付其他与筹资活动有关的现金103,495,393.2267,570,243.9239,408,192.35130,194,249.04
  筹资活动现金流出小计1,162,426,551.89852,672,633.2192,664,302.091,706,924,328.71
  筹资活动产生的现金流量净额-946,426,551.89-636,672,633.2-86,664,302.09-1,387,476,607.51
五、现金及现金等价物净增加额-3,671,237,591.76-2,751,186,159.6-3,682,935,874.22600,652,215.34
  加:期初现金及现金等价物余额8,892,046,272.38,892,046,272.38,892,046,272.38,291,394,056.96
  期末现金及现金等价物余额5,220,808,680.546,140,860,112.75,209,110,398.088,892,046,272.3
补充资料:
  净利润-874,248,629.54-2,089,403,586
  资产减值准备-47,378,719.81-5,563,843.29
  固定资产和投资性房地产折旧-33,978,673.1-73,297,846.2
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,978,673.1-73,297,846.2
  无形资产摊销-26,818,931.77-54,366,923.24
  长期待摊费用摊销-4,289,706.64-10,067,575.5
  处置固定资产、无形资产和其他长期资产的损失-20,108.4--212,185.96
  固定资产报废损失---102,985.11
  公允价值变动损失----66,164.34
  财务费用-10,785,139.64-27,165,852.32
  投资损失--286,926,112.79--585,314,905.57
  递延所得税--18,096,209.99--20,566,368.53
  其中:递延所得税资产减少--15,906,233.7--14,177,873.67
    递延所得税负债增加--2,189,976.29--6,388,494.86
  存货的减少--274,551,573.66--240,873,051.48
  经营性应收项目的减少--2,465,680,181.47--692,570,321.85
  经营性应付项目的增加--705,639,822.14-1,140,496,132.06
  其他-574,495.08--
  现金的期末余额-6,140,860,112.7-8,892,046,272.3
  减:现金的期初余额-8,892,046,272.3-8,291,394,056.96
  现金及现金等价物的净增加额--2,751,186,159.6-600,652,215.34
公告日期2026-10-212026-08-202026-04-232026-03-20
审计意见(境内)标准无保留意见
TOP↑